TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T85943	Proto-oncogene c-Src	B0CWL3	(3S)-3-[[(2S)-2-Acetamido-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-oxobutanoic acid	Investigative	44353828	C26H40N5O11P	629.6	CC(C)C[C@@H](C(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C	IC50 = 261000 nM	Non binder
T85943	Proto-oncogene c-Src	B0U7ZS	3-(2-{(S)-1-[(S)-1-((S)-(S)-1-Carbamoyl-2-methyl-butylcarbamoyl)-3-carboxy-propylcarbamoyl]-3-carboxy-propylcarbamoyl}-ethyl)-benzoic acid	Investigative	44291065	C26H36N4O10	564.6	CC[C@H](C)[C@@H](C(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CCC1=CC(=CC=C1)C(=O)O	IC50 = 250000 nM	Non binder
T85943	Proto-oncogene c-Src	B14TNV	(S)-4-[(S)-2-Acetylamino-3-(4-phosphonooxy-phenyl)-propionylamino]-4-(4-isobutyl-thiazol-2-yl)-butyric acid	Investigative	44315734	C22H30N3O8PS	527.5	CC(C)CC1=CSC(=N1)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)OP(=O)(O)O)NC(=O)C	IC50 = 218000 nM	Non binder
T85943	Proto-oncogene c-Src	B16JUL	Phosphoric acid mono-(8-hydroxy-3,4-dihydro-2H-quinolin-1-yl) ester	Investigative	44459744	C9H12NO5P	245.17	C1CC2=C(C(=CC=C2)O)N(C1)OP(=O)(O)O	IC50 = 300000 nM	Non binder
T85943	Proto-oncogene c-Src	B2BA6O	(3S,6S,9S,12S,15S,18S,21S,24S)-3,9,15,21-Tetrakis(4-aminobutyl)-6,12,18,24-tetramethyl-1,4,7,10,13,16,19,22-octazacyclotetracosane-2,5,8,11,14,17,20,23-octone	Investigative	73356485	C36H68N12O8	797	C[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCCCN)C)CCCCN)C)CCCCN)C)CCCCN	IC50 >= 300000 nM	Non binder
T85943	Proto-oncogene c-Src	B2BI5Q	1,2,4-Oxadiazole Analogue 4g	Investigative	5329183	C24H26Cl2N5O8P	614.4	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC(=O)N)C2=NC(=NO2)CC3=C(C=C(C=C3)Cl)Cl	IC50 > 500000 nM	Non binder
T85943	Proto-oncogene c-Src	B2D8OP	1,2,4-Oxadiazole Analogue 4j	Investigative	5329216	C28H30N5O8P	595.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC(=O)N)C2=NC(=NO2)CC3=CC4=CC=CC=C4C=C3	IC50 = 274000 nM	Non binder
T85943	Proto-oncogene c-Src	B2MR5Y	{(S)-2-[4-(Benzyloxy-hydroxy-phosphoryloxy)-phenyl]-1-[2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylcarbamoyl]-ethyl}-carbamic acid tert-butyl ester	Investigative	44307684	C37H40N3O9PS	733.8	CC(C)(C)OC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)OCC2=CC=CC=C2)C(=O)NC3C(SC4=CC=CC=C4NC3=O)C5=CC=C(C=C5)OC	IC50 = 873000 nM	Non binder
T85943	Proto-oncogene c-Src	B3C9KW	(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-3-methylpentanoyl]amino]-3-(4-aminophenyl)propanoyl]amino]-6-aminohexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	11593162	C44H60N8O10S	893.1	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)C	IC50 = 760000 nM	Non binder
T85943	Proto-oncogene c-Src	B3QO1I	[4-[(2S)-2-Acetamido-3-[[3-(cyclohexylmethyl)-1,2,4-oxadiazol-5-yl]methylamino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	44315770	C21H29N4O7P	480.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NCC2=NC(=NO2)CC3CCCCC3	IC50 = 896000 nM	Non binder
T85943	Proto-oncogene c-Src	B43NXA	3-[(2S,5S,8S,11S,14S,17S,20S,23S)-5,11,17,23-Tetrakis(4-aminobutyl)-8,14,20-tris(2-carboxyethyl)-3,6,9,12,15,18,21,24-octaoxo-1,4,7,10,13,16,19,22-octazacyclotetracos-2-yl]propanoic acid	Investigative	73347352	C44H76N12O16	1029.099	C(CCN)C[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1)CCC(=O)O)CCCCN)CCC(=O)O)CCCCN)CCC(=O)O)CCCCN)CCC(=O)O	IC50 >= 300000 nM	Non binder
T85943	Proto-oncogene c-Src	B4ESV1	(E)-1-(3-(2-(6-(Cyclopropylamino)-9H-purin-9-yl)vinyl)-4-methylphenyl)-3-(3-(trifluoromethyl)phenyl)urea	Investigative	44222636	C25H22F3N7O	493.5	CC1=C(C=C(C=C1)NC(=O)NC2=CC=CC(=C2)C(F)(F)F)/C=C/N3C=NC4=C(N=CN=C43)NC5CC5	IC50 = 517000 nM	Non binder
T85943	Proto-oncogene c-Src	B4F6AY	[4-[(2S)-2-Acetamido-3-[[(1S)-4-amino-4-oxo-1-[3-[(4,6,6-trimethylcyclohexa-2,4-dien-1-yl)methyl]-1,2,4-oxadiazol-5-yl]butyl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	44353827	C27H36N5O8P	589.6	CC1=CC(C(C=C1)CC2=NOC(=N2)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C)(C)C	IC50 = 312000 nM	Non binder
T85943	Proto-oncogene c-Src	B4Q2LW	(2R,3S,4R,5S)-2-(Hydroxymethyl)-5-(4-methoxyphenoxy)oxolane-3,4-diol	Investigative	58159418	C12H16O6	256.25	COC1=CC=C(C=C1)O[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O	IC50 = 483900 nM	Non binder
T85943	Proto-oncogene c-Src	B50LRI	[(R)-1-[5-(3-Cyclohexyl-propyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-ylcarbamoyl]-2-(4-phosphonooxy-phenyl)-ethyl]-carbamic acid tert-butyl ester	Investigative	44307793	C32H44N3O8PS	661.7	CC(C)(C)OC(=O)N[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NC2CSC3=CC=CC=C3N(C2=O)CCCC4CCCCC4	IC50 = 422000 nM	Non binder
T85943	Proto-oncogene c-Src	B5DB9J	(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-(3-methylphenoxy)oxolane-3,4-diol	Investigative	71450496	C12H16O5	240.25	CC1=CC(=CC=C1)O[C@@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O	IC50 = 451000 nM	Non binder
T85943	Proto-oncogene c-Src	B5FD4Y	(5-{2-[1-(3-Carbamoyl-4-cyclohexylmethoxy-phenyl)-1-methyl-ethylcarbamoyl]-ethyl}-2-hydroxy-phenyl)-phosphonic acid	Investigative	44314402	C26H35N2O7P	518.5	CC(C)(C1=CC(=C(C=C1)OCC2CCCCC2)C(=O)N)NC(=O)CCC3=CC(=C(C=C3)O)P(=O)(O)O	IC50 > 500000 nM	Non binder
T85943	Proto-oncogene c-Src	B7DXG4	10-Ethyl-5,10-dihydro-3H-pyrimido[4,5-b]quinolin-4-one	Investigative	136023327	C13H13N3O	227.26	CCN1C2=CC=CC=C2CC3=C1N=CNC3=O	IC50 = 550000 nM	Non binder
T85943	Proto-oncogene c-Src	B7GT4L	N-[(S)-1-[3-(3,4-Dichlorobenzyl)-1,2,4-oxadiazole-5-yl]ethyl]-4-(phosphonooxy)benzenepropanamide	Investigative	12968819	C20H20Cl2N3O6P	500.3	C[C@@H](C1=NC(=NO1)CC2=CC(=C(C=C2)Cl)Cl)NC(=O)CCC3=CC=C(C=C3)OP(=O)(O)O	IC50 = 459000 nM	Non binder
T85943	Proto-oncogene c-Src	B7JYB4	N-(5-Tert-butyl-1,3-thiazol-2-yl)-3-[(E)-2-[6-(cyclopropylamino)purin-9-yl]ethenyl]-4-methylbenzamide	Investigative	44222458	C25H27N7OS	473.6	CC1=C(C=C(C=C1)C(=O)NC2=NC=C(S2)C(C)(C)C)/C=C/N3C=NC4=C(N=CN=C43)NC5CC5	IC50 = 310000 nM	Non binder
T85943	Proto-oncogene c-Src	B8FPC7	(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-3-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-aminohexanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	56664629	C44H59N7O10S	878	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)C	IC50 > 700000 nM	Non binder
T85943	Proto-oncogene c-Src	B8NJI9	4-{[(S)-1-(3-Methoxy-benzylcarbamoyl)-2-phenyl-ethylcarbamoyl]-methoxy}-pyridine-2,6-dicarboxylic acid dimethyl ester	Investigative	44393412	C28H29N3O8	535.5	COC1=CC=CC(=C1)CNC(=O)[C@H](CC2=CC=CC=C2)NC(=O)COC3=CC(=NC(=C3)C(=O)OC)C(=O)OC	IC50 = 663000 nM	Non binder
T85943	Proto-oncogene c-Src	B8PU2Q	(E)-N-(4-Methyl-3-(2-(6-(pyridine-2-yl-amino)-9H-purin-9-yl)vinyl)phenyl)-3-(trifluoromethyl)-benzamide	Investigative	44222109	C27H20F3N7O	515.5	CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)/C=C/N3C=NC4=C(N=CN=C43)NC5=CC=CC=N5	IC50 = 201000 nM	Non binder
T85943	Proto-oncogene c-Src	B8QY4O	1,2,4-Oxadiazole Analogue 4b	Investigative	5329179	C25H30N5O8P	559.5	CC1=CC=C(C=C1)CC2=NOC(=N2)[C@H](CCC(=O)N)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 292000 nM	Non binder
T85943	Proto-oncogene c-Src	BA06QG	4-({(S)-1-[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-2-phenyl-ethylcarbamoyl}-methoxy)-pyridine-2,6-dicarboxylic acid dimethyl ester	Investigative	44393373	C28H27N3O9	549.5	COC(=O)C1=CC(=CC(=N1)C(=O)OC)OCC(=O)N[C@@H](CC2=CC=CC=C2)C(=O)NCC3=CC4=C(C=C3)OCO4	IC50 = 396000 nM	Non binder
T85943	Proto-oncogene c-Src	BA1XY4	(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-3-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-aminohexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	56681625	C44H59N7O11S	894	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)C	IC50 = 400000 nM	Non binder
T85943	Proto-oncogene c-Src	BA5S8J	4-Aminophenyl phosphate	Investigative	122271	C6H8NO4P	189.11	C1=CC(=CC=C1N)OP(=O)(O)O	IC50 = 600000 nM	Non binder
T85943	Proto-oncogene c-Src	BAB13W	Cyclo[Ac-Cys-Ile-Tyr-Lys-Phe]-Tyr	Investigative	11586070	C46H60N8O11S	933.1	CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC2=CC=C(C=C2)NC(=O)CCC(=O)N[C@H](C(=O)N1)CS)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)CCCCN)CC4=CC=C(C=C4)O	IC50 > 400000 nM	Non binder
T85943	Proto-oncogene c-Src	BAZK09	1,2,4-Oxadiazole Analogue 12d	Investigative	5329222	C23H24F3N4O8P	572.4	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CO)C2=NC(=NO2)CC3=CC=C(C=C3)C(F)(F)F	IC50 = 282000 nM	Non binder
T85943	Proto-oncogene c-Src	BB2PT6	1,2,4-Oxadiazole Analogue 7	Investigative	5329199	C22H22F3N4O7P	542.4	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NCC2=NC(=NO2)CC3=CC=C(C=C3)C(F)(F)F	IC50 > 500000 nM	Non binder
T85943	Proto-oncogene c-Src	BCU0E2	1,2,4-Oxadiazole Analogue 8	Investigative	5329200	C23H24F3N4O7P	556.4	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NCCC2=NC(=NO2)CC3=CC=C(C=C3)C(F)(F)F	IC50 > 500000 nM	Non binder
T85943	Proto-oncogene c-Src	BDA7S1	1,2,4-Oxadiazole Analogue 4e	Investigative	5329182	C24H27ClN5O8P	579.9	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC(=O)N)C2=NC(=NO2)CC3=CC(=CC=C3)Cl	IC50 = 259000 nM	Non binder
T85943	Proto-oncogene c-Src	BE12XM	(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-3-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-aminohexanoyl]amino]-3-[4-(methanesulfonamido)phenyl]propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	11498974	C45H62N8O12S2	971.2	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)NS(=O)(=O)C)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)C	IC50 > 700000 nM	Non binder
T85943	Proto-oncogene c-Src	BE3V4O	1,2,4-Oxadiazole Analogue 4d	Investigative	5329181	C24H27ClN5O8P	579.9	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC(=O)N)C2=NC(=NO2)CC3=CC=C(C=C3)Cl	IC50 = 205000 nM	Non binder
T85943	Proto-oncogene c-Src	BEYC70	[5-{2-[1-(3-Carbamoyl-4-cyclohexylmethoxy-phenyl)-1-methyl-ethylcarbamoyl]-ethyl}-2-(tetrazol-1-ylmethoxy)-phenyl]-phosphonic acid	Investigative	44313990	C28H37N6O7P	600.6	CC(C)(C1=CC(=C(C=C1)OCC2CCCCC2)C(=O)N)NC(=O)CCC3=CC(=C(C=C3)OCN4C=NN=N4)P(=O)(O)O	IC50 > 500000 nM	Non binder
T85943	Proto-oncogene c-Src	BH4JR7	Benzyl [4-[3-[[2-(4-methoxyphenyl)-5-[2-(naphthalen-1-ylmethylamino)-2-oxoethyl]-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl]amino]-3-oxopropyl]phenyl] hydrogen phosphate	Investigative	44308217	C45H42N3O8PS	815.9	COC1=CC=C(C=C1)C2C(C(=O)N(C3=CC=CC=C3S2)CC(=O)NCC4=CC=CC5=CC=CC=C54)NC(=O)CCC6=CC=C(C=C6)OP(=O)(O)OCC7=CC=CC=C7	IC50 = 339000 nM	Non binder
T85943	Proto-oncogene c-Src	BH8JE9	[4-[(2S)-2-(Tert-butylsulfonylmethyl)-3-oxo-3-[[(1S)-1-[3-[[4-(trifluoromethyl)phenyl]methyl]-1,2,4-oxadiazol-5-yl]ethyl]amino]propyl]phenyl] dihydrogen phosphate	Investigative	12968822	C26H31F3N3O8PS	633.6	C[C@@H](C1=NC(=NO1)CC2=CC=C(C=C2)C(F)(F)F)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)CS(=O)(=O)C(C)(C)C	IC50 = 205000 nM	Non binder
T85943	Proto-oncogene c-Src	BHJO37	[4-[(2S)-2-Acetamido-3-[[(1S)-4-amino-1-[3-(3-methylbutyl)-1,2,4-oxadiazol-5-yl]-4-oxobutyl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	44315899	C22H32N5O8P	525.5	CC(C)CCC1=NOC(=N1)[C@H](CCC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)OP(=O)(O)O)NC(=O)C	IC50 = 320000 nM	Non binder
T85943	Proto-oncogene c-Src	BHXT24	(2-Formyl-4-methyl-phenyl)-acetic acid	Investigative	10261645	C10H10O3	178.18	CC1=CC(=C(C=C1)CC(=O)O)C=O	IC50 = 385000 nM	Non binder
T85943	Proto-oncogene c-Src	BJ0MB7	[Hydroxy-(6-nitro-1,3-benzodioxol-5-yl)methyl]phosphonic acid	Investigative	23646845	C8H8NO8P	277.12	C1OC2=C(O1)C=C(C(=C2)C(O)P(=O)(O)O)[N+](=O)[O-]	IC50 = 300000 nM	Non binder
T85943	Proto-oncogene c-Src	BL1B2C	4-(Benzyloxy)phenylcarbamoylphosphonic acid	Investigative	11722723	C14H14NO5P	307.24	C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)P(=O)(O)O	IC50 = 800000 nM	Non binder
T85943	Proto-oncogene c-Src	BL45TP	N-(4-Methyl-3-(2-(6-(methylamino)-9H-purin-9-yl)ethyl)phenyl)-3-(trifluoromethyl)-benzamide	Investigative	23649898	C23H21F3N6O	454.4	CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)CCN3C=NC4=C(N=CN=C43)NC	IC50 = 300000 nM	Non binder
T85943	Proto-oncogene c-Src	BLX6A5	5-{[(S)-1-(4-Methoxy-benzylcarbamoyl)-3-methyl-butylcarbamoyl]-methoxy}-isophthalic acid	Investigative	44393241	C24H28N2O8	472.5	CC(C)C[C@@H](C(=O)NCC1=CC=C(C=C1)OC)NC(=O)COC2=CC(=CC(=C2)C(=O)O)C(=O)O	IC50 = 864000 nM	Non binder
T85943	Proto-oncogene c-Src	BN08BD	[4-[(2S)-2-Acetamido-3-[[3-(cyclohexylmethyl)phenyl]methylamino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	10096996	C25H33N2O6P	488.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NCC2=CC=CC(=C2)CC3CCCCC3	IC50 = 769000 nM	Non binder
T85943	Proto-oncogene c-Src	BN14WA	{4-[2-Acetylamino-2-(3-carbamoyl-4-cyclohexylmethoxy-benzylcarbamoyl)-ethyl]-2-phosphono-phenoxy}-acetic acid	Investigative	44313930	C28H36N3O10P	605.6	CC(=O)NC(CC1=CC(=C(C=C1)OCC(=O)O)P(=O)(O)O)C(=O)NCC2=CC(=C(C=C2)OCC3CCCCC3)C(=O)N	IC50 = 378000 nM	Non binder
T85943	Proto-oncogene c-Src	BN2U6W	(2R,3S,4R,5S)-2-(Hydroxymethyl)-5-naphthalen-2-yloxyoxolane-3,4-diol	Investigative	71454126	C15H16O5	276.28	C1=CC=C2C=C(C=CC2=C1)O[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	IC50 = 224800 nM	Non binder
T85943	Proto-oncogene c-Src	BNOK94	Ac-Cys-Tyr-Lys-Tyr(4-PO3H2)-Tyr	Investigative	44412002	C38H49N6O12PS	844.9	CC(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)P(=O)(O)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O	IC50 > 700000 nM	Non binder
T85943	Proto-oncogene c-Src	BO1U8K	4-{[(S)-1-(3-Methoxy-benzylcarbamoyl)-2-methyl-propylcarbamoyl]-methoxy}-pyridine-2,6-dicarboxylic acid dimethyl ester	Investigative	44393258	C24H29N3O8	487.5	CC(C)[C@@H](C(=O)NCC1=CC(=CC=C1)OC)NC(=O)COC2=CC(=NC(=C2)C(=O)OC)C(=O)OC	IC50 = 713000 nM	Non binder
T85943	Proto-oncogene c-Src	BQ69ZR	(2S)-2-[[(12S,15S)-12-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-3-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3,6,13-trioxo-2,7,14-triazabicyclo[15.2.2]henicosa-1(19),17,20-triene-15-carbonyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	11672471	C48H62N8O12S	975.1	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@H]2CCCCNC(=O)CCC(=O)NC3=CC=C(C[C@H](NC2=O)C(=O)N[C@@H](CC4=CC=C(C=C4)O)C(=O)O)C=C3)NC(=O)[C@H](CS)NC(=O)C	IC50 > 400000 nM	Non binder
T85943	Proto-oncogene c-Src	BQR4J7	3-[(2S,5S,8S,11S,14S,17S,20S,23S)-5,11,17,23-Tetrabenzyl-14-(2-carboxyethyl)-8,20-bis[3-(diaminomethylideneamino)propyl]-3,6,9,12,15,18,21,24-octaoxo-1,4,7,10,13,16,19,22-octazacyclotetracos-2-yl]propanoic acid	Investigative	73356487	C58H74N14O12	1159.3	C1=CC=C(C=C1)C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N2)CCCN=C(N)N)CC3=CC=CC=C3)CCC(=O)O)CC4=CC=CC=C4)CCCN=C(N)N)CC5=CC=CC=C5)CCC(=O)O	IC50 >= 300000 nM	Non binder
T85943	Proto-oncogene c-Src	BR0A8S	Trifluoro-methanesulfonic acid 4-{2-[1-(3-carbamoyl-4-cyclohexylmethoxy-phenyl)-1-methyl-ethylcarbamoyl]-ethyl}-2-phosphono-phenyl ester	Investigative	44313929	C27H34F3N2O9PS	650.6	CC(C)(C1=CC(=C(C=C1)OCC2CCCCC2)C(=O)N)NC(=O)CCC3=CC(=C(C=C3)OS(=O)(=O)C(F)(F)F)P(=O)(O)O	IC50 > 500000 nM	Non binder
T85943	Proto-oncogene c-Src	BR29LT	1,2,4-Oxadiazole Analogue 6	Investigative	5329198	C24H26F3N4O7P	570.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NC(C)(C)C2=NC(=NO2)CC3=CC=C(C=C3)C(F)(F)F	IC50 = 489000 nM	Non binder
T85943	Proto-oncogene c-Src	BR7T9F	Ac-Cys-Ile-Tyr-Lys-Tyr(4-PO3H2)-Tyr	Investigative	44412134	C44H60N7O13PS	958	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)P(=O)(O)O)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)C	IC50 > 700000 nM	Non binder
T85943	Proto-oncogene c-Src	BS27QE	(2R,3S,4R,5R)-2-(Hydroxymethyl)-5-naphthalen-2-yloxyoxolane-3,4-diol	Investigative	71450494	C15H16O5	276.28	C1=CC=C2C=C(C=CC2=C1)O[C@@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O	IC50 = 297300 nM	Non binder
T85943	Proto-oncogene c-Src	BS57PM	(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-3-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-aminohexanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-aminophenyl)propanoic acid	Investigative	11722068	C44H60N8O10S	893.1	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CC3=CC=C(C=C3)N)C(=O)O)NC(=O)[C@H](CS)NC(=O)C	IC50 > 700000 nM	Non binder
T85943	Proto-oncogene c-Src	BS70HI	1,2,4-Oxadiazole Analogue 4f	Investigative	5329215	C24H26Cl2N5O8P	614.4	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CCC(=O)N)C2=NC(=NO2)CC3=CC(=C(C=C3)Cl)Cl	IC50 = 206000 nM	Non binder
T85943	Proto-oncogene c-Src	BSJ1A8	[4-[(2S)-2-Acetamido-3-[[4-(cyclohexylmethyl)-1,3-thiazol-2-yl]methylamino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	9870411	C22H30N3O6PS	495.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)NCC2=NC(=CS2)CC3CCCCC3	IC50 = 483000 nM	Non binder
T85943	Proto-oncogene c-Src	BT28AR	(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3S)-2-[[(2R)-2-Acetamido-3-sulfanylpropanoyl]amino]-3-methylpentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-6-aminohexanoyl]amino]-3-[4-(diaminomethylideneamino)phenyl]propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid	Investigative	11643683	C45H62N10O10S	935.1	CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC2=CC=C(C=C2)N=C(N)N)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CS)NC(=O)C	IC50 > 700000 nM	Non binder
T85943	Proto-oncogene c-Src	BTEV27	4-[({(S)-[(Benzo[1,3]dioxol-5-ylmethyl)-carbamoyl]-phenyl-methyl}-carbamoyl)-methoxy]-pyridine-2,6-dicarboxylic acid dimethyl ester	Investigative	44393404	C27H25N3O9	535.5	COC(=O)C1=CC(=CC(=N1)C(=O)OC)OCC(=O)N[C@@H](C2=CC=CC=C2)C(=O)NCC3=CC4=C(C=C3)OCO4	IC50 = 714000 nM	Non binder
T85943	Proto-oncogene c-Src	BTP30D	(4-{2-Acetylamino-2-[(S)-1-(3-carbamoyl-4-cyclohexylmethoxy-phenyl)-ethylcarbamoyl]-ethyl}-phenoxy)-acetic acid	Investigative	44314372	C29H37N3O7	539.6	C[C@@H](C1=CC(=C(C=C1)OCC2CCCCC2)C(=O)N)NC(=O)C(CC3=CC=C(C=C3)OCC(=O)O)NC(=O)C	IC50 = 370000 nM	Non binder
T85943	Proto-oncogene c-Src	BU4N8A	3H-Pyrimido[4,5-B]indol-4(9H)-one	Investigative	135436036	C10H7N3O	185.18	C1=CC=C2C(=C1)C3=C(N2)N=CNC3=O	IC50 = 293000 nM	Non binder
T85943	Proto-oncogene c-Src	BU8NR7	[4-[(2S)-2-Acetamido-3-[[(1S)-2-(1H-indol-3-yl)-1-[3-(naphthalen-1-ylmethyl)-1,2,4-oxadiazol-5-yl]ethyl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	44315713	C34H32N5O7P	653.6	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C4=NC(=NO4)CC5=CC=CC6=CC=CC=C65	IC50 = 279000 nM	Non binder
T85943	Proto-oncogene c-Src	BUW17J	[4-[(2S)-2-Acetamido-3-[[(1S)-1-[3-(cyclohexylmethyl)phenyl]propyl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	44315296	C27H37N2O6P	516.6	CC[C@@H](C1=CC=CC(=C1)CC2CCCCC2)NC(=O)[C@H](CC3=CC=C(C=C3)OP(=O)(O)O)NC(=O)C	IC50 = 306000 nM	Non binder
T85943	Proto-oncogene c-Src	BV5E0M	(2R,3S,4R,5S)-2-(Hydroxymethyl)-5-(4-hydroxyphenoxy)oxolane-3,4-diol	Investigative	44198001	C11H14O6	242.22	C1=CC(=CC=C1O)O[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O	IC50 = 272100 nM	Non binder
T85943	Proto-oncogene c-Src	BW24GD	1,2,4-Oxadiazole Analogue 9	Investigative	5329201	C24H25F3N5O8P	599.5	CC(=O)N[C@@H](CC1=CC=C(C=C1)OP(=O)(O)O)C(=O)N[C@@H](CC(=O)N)C2=NC(=NO2)CC3=CC=C(C=C3)C(F)(F)F	IC50 > 500000 nM	Non binder
T85943	Proto-oncogene c-Src	BW2X1K	Ac-YEEIE	Investigative	446044	C32H45N5O14	723.7	CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)C	IC50 > 200000 nM	Non binder
T85943	Proto-oncogene c-Src	BWAR36	{4-[2-Acetylamino-2-(3-carbamoyl-4-cyclohexylmethoxy-phenylcarbamoyl)-ethyl]-2-phosphono-phenoxy}-acetic acid	Investigative	44314373	C27H34N3O10P	591.5	CC(=O)NC(CC1=CC(=C(C=C1)OCC(=O)O)P(=O)(O)O)C(=O)NC2=CC(=C(C=C2)OCC3CCCCC3)C(=O)N	IC50 > 500000 nM	Non binder
T85943	Proto-oncogene c-Src	BWD56I	[4-[(2S)-2-Acetamido-3-[[(1S)-4-amino-1-(3-butyl-1,2,4-oxadiazol-5-yl)-4-oxobutyl]amino]-3-oxopropyl]phenyl] dihydrogen phosphate	Investigative	44315898	C21H30N5O8P	511.5	CCCCC1=NOC(=N1)[C@H](CCC(=O)N)NC(=O)[C@H](CC2=CC=C(C=C2)OP(=O)(O)O)NC(=O)C	IC50 = 384000 nM	Non binder
T85943	Proto-oncogene c-Src	BWVK17	(4S)-4-[[(2S)-2-[[(2S)-2-Acetamido-3-(4-phosphonooxyphenyl)propanoyl]amino]-4-amino-4-oxobutanoyl]amino]-5-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-5-oxopentanoic acid	Investigative	44353815	C26H39N6O12P	658.6	CC(C)C[C@@H](C(=O)N)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)OP(=O)(O)O)NC(=O)C	IC50 = 237000 nM	Non binder
T85943	Proto-oncogene c-Src	BXT1V4	Asp-Arg-Val-Tyr-Val-His-Pro-Phe	Investigative	9811952	C49H69N13O12	1032.2	CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CC4=CC=CC=C4)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N	Ki = 700000 nM	Non binder
T85943	Proto-oncogene c-Src	BY26TI	Phosphoric acid 3-formylphenyl ester	Investigative	44459920	C7H7O5P	202.1	C1=CC(=CC(=C1)OP(=O)(O)O)C=O	IC50 = 600000 nM	Non binder
T85943	Proto-oncogene c-Src	BZ1TW5	Phosphoric acid 2,6-diformylphenyl ester	Investigative	44274805	C8H7O6P	230.11	C1=CC(=C(C(=C1)C=O)OP(=O)(O)O)C=O	IC50 = 500000 nM	Non binder
T85943	Proto-oncogene c-Src	D06KSF	Tpl2 kinase inhibitor	Investigative	9549300	C21H14ClFN6	404.8	C1=CC(=CN=C1)CNC2=NC=C3C(=C2)C(=C(C=N3)C#N)NC4=CC(=C(C=C4)F)Cl	IC50 > 400000 nM	Non binder